May Measurement Month 2019: an analysis of blood pressure screening results from Cameroon.
Awareness
Blood pressure
Control
Hypertension
Screening
Treatment
Journal
European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
12
7
2021
pubmed:
13
7
2021
medline:
13
7
2021
Statut:
epublish
Résumé
The multi-country May Measurement Month (MMM) screening campaign aims to raise awareness on blood pressure (BP) and hypertension in individuals and communities, and measure BP, ideally, of those who had no BP measurement in the preceding year. We here report key findings from the Cameroon arm of MMM 2019. An opportunistic sample of adults (≥18 years) was included from 5 May to 5 June 2019 across 15 sites (markets, churches, homes, motor parks, workplaces, and hospitals/clinics). Data collection, cleaning, the definition of hypertension, and statistical analysis followed the standard protocol. The mean age of the 30 187 participants screened was 36.9 (SD: 14.9) years, 50.4% were female (5% of whom were pregnant), and 94.4% were screened out of the hospital/clinic settings. After multiple imputation of missing data, 6286 (20.8%) had hypertension, 24.0% were taking antihypertensive medication, and 705 (11.2%) of all participants with hypertension had controlled BP. In linear regression models adjusted for age, sex, and antihypertensive medicines use, a previous diagnosis of hypertension, a history of stroke, and use of antihypertensive medicines were significant predictors of systolic and diastolic BP levels. BPs were also significantly higher when measured in public outdoors, public indoors (diastolic BP only), workplaces, and other unspecified areas compared to hospitals/clinic settings. MMM19 is the largest ever BP screening campaign in a single month, in Cameroon and despite the limitations resulting from non-random sample selection, the opportunistic screening allows access to awareness and screening for hypertension out of the hospital/clinic settings.
Identifiants
pubmed: 34248429
doi: 10.1093/eurheartj/suab056
pii: suab056
pmc: PMC8263083
doi:
Types de publication
Journal Article
Langues
eng
Pagination
B33-B36Informations de copyright
Published on behalf of the European Society of Cardiology. © The Author(s) 2021.
Références
Eur Heart J Suppl. 2019 Apr;21(Suppl D):D31-D33
pubmed: 31043871
Hypertension. 2020 Aug;76(2):333-341
pubmed: 32419505
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H33-H36
pubmed: 32884464
Cardiovasc J Afr. 2017 Jul/Aug;28(4):262-272
pubmed: 28906541
Nat Rev Nephrol. 2020 Apr;16(4):223-237
pubmed: 32024986
J Hypertens. 2019 Jun;37(6):1148-1153
pubmed: 30624370
J Hypertens. 2019 Nov;37(11):2190-2199
pubmed: 31166251